Acute and Subchronic Inhalation Toxicity of Chloroform in Rats and Mice

Size: px
Start display at page:

Download "Acute and Subchronic Inhalation Toxicity of Chloroform in Rats and Mice"

Transcription

1 J Occup Health 2002; 44: Journal of Occupational Health Rapid Communication Acute and Subchronic Inhalation Toxicity of Chloroform in Rats and Mice Tatsuya KASAI 1, Tomoshi NISHIZAWA 1, Heihachiro ARITO 1, Kasuke NAGANO 1, Seigo YAMAMOTO 1, Taijiro MATSUSHIMA 1 and Toshihiro KAWAMOTO 2 1 Japan Bioassay Research Center, Japan Industrial Safety and Health Association and 2 University of Occupational and Environmental Health, School of Medicine, Department of Environmental Health, Japan Abstract: Acute and Subchronic Inhalation Toxicity of Chloroform in Rats and Mice: Tatsuya KASAI, et al. Japan Bioassay Research Center In order to better characterize acute and subchronic toxicities of chloroform and to provide its basic toxicity data for risk assessment of humans exposed to chloroform in work and living environments, mice and rats of both sexes were exposed by inhalation to chloroform at different concentrations from 500 to 8,000 ppm for 6 h/d 5 d/ wk 2 wk and from 12 to 400 ppm for 6 h/d 5 d/wk 13 wk. The kidneys, liver and nasal cavity were primarily damaged by the inhalation exposure. Acute death occurred at 12 ppm in male mice, 1,000 ppm in female mice and 2,000 ppm in male and female rats. The 13-wk exposures induced renal lesions in male mice, hepatic and nasal lesions in female mice and renal, hepatic and nasal lesions in male and female rats. Susceptibility to the acute and subchronic toxicities was higher in male mice than female mice, and higher in mice than in rats. No-observed-adverseeffect-levels (NOAELs) and lowest-observed-adverseeffect-levels (LOAELs) were determined for the renal, hepatic and nasal endpoints of animals exposed to chloroform for 13 wk. For the hepatic endpoint, NOAEL was 100 ppm in male mice, 50 ppm in female mice and female rats and 100 ppm in male rats. For the renal endpoint, LOAEL was 12 ppm in male mice, and NOAEL was 25 ppm in male rats and 100 ppm in female rats. For the nasal endpoint, LOAEL was 12 ppm and 25 ppm in the mice and the rats of both sexes, respectively. (J Occup Health 2002; 44: ) Key words: Chloroform, Rat, Mouse, NOAEL, LOAEL, Liver, Kidney, Nasal organ, Occupational exposure limit Received March 28, 2002; Accepted June 4, 2002 Correspondence to: T. Kasai, Japan Bioassay Research Center, 2445 Hirasawa, Hadano, Kanagawa , Japan Chloroform has been widely used as an organic solvent, an intermediate for the synthesis of fluorocarbons and drugs, and an insecticidal fumigant. Annual production and importation of chloroform in Japan were reported to amount to 37,000 and 61,000 tons in 2000, respectively 1). Approximately 96,000 workers in the U.S. were exposed to chloroform according to the National Occupational Exposure Survey 2). Chloroform is also a major environmental contaminant formed in the chlorination of drinking water in the community and cooling water in power plant and in the process of bleaching paper 3). This compound poses a potential hazard to the health of workers and community residents exposed to chloroform in the workplace and in drinking water. The American Conference of Governmental Industrial Hygienists (ACGIH) 4, 5) and the Japan Society for Occupational Health (JSOH) 6, 7) recommended an occupational exposure limit (OEL) of 10 ppm for chloroform, and a MAK value of 0.5 ppm (2.5 mg/m 3 ) was established in Germany 8). Those three OELs were derived primarily from bioassay data of rodents exposed to chloroform vapor by inhalation. Acute and chronic toxicities of chloroform in humans and experimental animals have been documented 9) but there are few published data available for health risk assessment of workers exposed to chloroform through the inhalation route. Inhalation and systemic exposure to chloroform are principal routes for workers, because chloroform is very volatile and permeable through the skin 10). The present study was intended to better characterize acute and subchronic toxicities of chloroform and to provide its basic toxicity data such as no-observed-adverseeffect levels (NOAELs) and lowest-observed-adverseeffect levels (LOAELs) for risk assessment of humans exposed to chloroform in work and living environments. We conducted experiments on inhalation exposure of rats and mice of both sexes to chloroform vapor for 2 and 13

2 194 J Occup Health, Vol. 44, 2002 wk, with reference to the Organization of Economic Cooperation and Development s (OECD) Guidelines for Testing of Chemicals 412 and 413, respectively 11). Another purpose of the present study was to determine an appropriate range of aerial concentrations for two-yr inhalation exposure of rodents to chloroform vapor for bioassay studies of carcinogenicity and chronic toxicity, and the results are published in a separate paper 12). Materials and Methods Animals F344/DuCrj rats and Crj:BDF1 mice of both sexes were purchased from Charles River Japan Inc. (Kanagawa, Japan) at 4 wk of age. The animals were quarantined and acclimated for 2 wk before the start of experiment. The animals were housed in six stainless-steel exposure chambers which were installed in a barrier system animal room maintained at a temperature of 22 ± 2 C and a relative humidity of 60 ± 10% with air changes per hour. Then the animals were housed individually in stainlesssteel wire hanging cages in the stainless steel inhalation exposure chambers maintained at a temperature of 23 ± 2 C and a relative humidity of 55 ± 10% with 12 air changes per hour. Fluorescent lighting was controlled automatically to give a 12-h light/dark cycle. All the animals had free access to sterilized water and commercial pellet diet (CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan). Exposure to chloroform The technique for generating chloroform vapor-air mixture and the exposure system used in the present study were described in detail in the previous paper 13). Chloroform of reagent grade (purity>99%) was obtained from Wako Pure Chemical Industries, Ltd (Tokyo, Japan). Each lot of chloroform was analyzed for its chemical purity and stability by gas chromatography and infrared spectrometry, but no impurities or decomposition products were observed. Experimental design For the 2-wk exposure study, groups of 10 rats and 10 mice of both sexes were exposed to air containing chloroform vapor at a concentration of 500, 1,000, 2,000, 4,000 or 8,000 ppm for 6 h/d 5 d/wk 2 wk. For the 13-wk exposure study, groups of 10 mice of both sexes were exposed to 12, 25, 50, 100 or 200 ppm chloroform vapor, and groups of 10 rats of both sexes to 25, 50, 100, 200 or 400 ppm chloroform vapor for 6 h/d 5 d/wk 13 wk. Groups of 10 rats and 10 mice of both sexes were exposed to clean air for 2 or 13 wk under the same conditions, and served as the respective controls. Clinical observations and analysis, and pathological examinaitions All animals were weighed and examined for clinical signs once a week. Food consumption was measured at the same time points as for the above parameters. Animals dead, found in a moribund state or surviving to the end of the 2- or 13-wk exposure study received complete necropsy. Urinary, hematological and blood biochemical parameters of all surviving animals were measured in urine sampled at the end of the 13-wk exposure and in blood samples taken under etherization after overnight fasting at the end of the exposure, respectively. All organs of the animals were removed and weighed at necropsy, and examined for macroscopically visible lesions. The tissues for microscopic examination were fixed in 10% neutral buffered formalin, embedded in paraffin. Sections of all tissues were made of 5 µm in thickness, and stained with hematoxylin and eosin. Statistical analysis Body weights, organ weights, and hematological and blood biochemical parameters were analyzed by the following algorithm 14, 15). The Bartlett s test was used to test whether the variance was homogeneous or not. When the variance was homogeneous, the one-way ANOVA was applied. When the variance was not homogeneous, the Kruskal-Wallis rank sum test was performed by arranging all data for the control and exposed groups in descending order. Statistical differences in the means and the rank means among the groups were analyzed by the Dunnett s multiple comparison test and the same multiple comparison test by rank, respectively. Two-sided analysis with a P-value of 0.05 was performed. Pathological examinations and urinary parameters were analyzed by the chi-square test with a P-value of Results Mortality Table 1 shows mortality rates for rats and mice of both sexes exposed to chloroform vapor for 2 or 13 wk. In the 2-wk exposure study, all the male mice except two died after the first or second day exposure to 500 ppm and above, and the two survived to the end of the 2-wk exposure. All the 500 ppm-exposed female mice survived, and one 1,000 ppm-exposed female mouse survived after the 2-wk exposures. All the male and female rats exposed to 2,000 ppm and above died after the first or second day of exposure. In the 13-wk exposure study, almost all the exposed male mice died after the first day of exposure, and the other male mice survived throughout the exposures. All the female mice and all the male and female rats survived after the 13-wk exposures to 12 ppm and above and 25 ppm and above, respectively. It was also worth noting that susceptibility to the acute and subchronic toxicities was much higher in male mice than in female mice, and also higher in mice than in rats, but no gender difference between male and female rats was observed in

3 Tatsuya KASAI, et al.: Acute and Subchronic Inhalation Toxicity of Chloroform 195 Table 1. Mortality rates for rats and mice of both sexes exposed to chloroform for 2 or 13 wk by inhalation Exposed Mice Exposed Rats conc. Male Female conc. Male Female 2W 0 ppm ppm ppm 9 (9/2 nd ) ppm 0 0 1,000 ppm 9 (9/2 nd ) 9 (4/4 th ) (4/5 th ) (1/6 th ) 1,000 ppm 0 0 2,000 ppm 10 (10/2 nd ) 10 (6/2 nd ) (2/4 th ) (2/5 th ) 2,000 ppm 10 (9/1 st ) (1/2 nd ) 10 (8/1 st ) (2/2 nd ) 4,000 ppm 10 (1/1 st ) (9/2 nd ) 10 (10/2 nd ) 4,000 ppm 10 (9/1 st ) (1/2 nd ) 10 (9/1 st ) (1/2 nd ) 8,000 ppm 10 (10/1 st ) 10 (10/1 st ) 8,000 ppm 10 (10/1 st ) 10 (10/1 st ) 13W 0 ppm ppm ppm 2 (1/1 st ) (1/3 rd ) 0 25 ppm ppm 9 (8/1 st ) (1/3 rd ) 0 50 ppm ppm 10 (7/1 st ) (3/2 nd ) ppm ppm 8 (8/1 st ) ppm ppm 10 (10/1 st ) ppm 0 0 The fraction within parenthesis indicates the number of dead animals as the numerator/the day of repeated exposure at death as the denominator. Fig. 1. Necrosis of proximal tubules in the kidney of a male mouse which died after the first day of exposure to 25 ppm chloroform. Fig. 2. Centrilobular necrosis in the liver of a female mouse which died after the second day of exposure to 2,000 ppm chloroform. susceptibility. The chloroform-induced deaths of mice were histopathologically attributed to necrosis (Fig. 1) of proximal tubules in males and to centrilobular necrosis (Fig. 2) of the liver in females. Both male and female rats exhibited no remarkable lesions indicative of the cause of chloroform-induced deaths, but congestion and inflammation of the lungs resulting presumably from cardiovascular effects of chloroform were noted, in addition to the below-mentioned histopathological changes in the kidneys and liver as seen in the rats which survived. Toxicity in surviving animals due to 2-wk exposure Surviving male mice exposed to 500 and 1,000 ppm exhibited necrosis and cytoplasmic basophilia of proximal tubules in the kidneys, slight swelling and vacuolic change in the liver, and atrophy and respiratory metaplasia in the olfactory epithelium. The female mice exposed to 500 and 1,000 ppm exhibited necrosis and vacuolic change in the central area of the liver, and degeneration, necrosis and disarrangement of the olfactory and respiratory epithelia, but no kidney lesions were observed in the exposed female mice. Surviving male and female rats exposed to 500 and 1,000 ppm had vacuolic changes in proximal tubules of the kidneys and in the central area of the liver, in addition to desquamation, atrophy and disarrangement of the olfactory epithelium and edema of the lamina propria of the nasal cavity. Subchronic toxicity due to 13-wk exposure General observations: No clinical signs or exposurerelated changes in gross findings were observed in either rats or mice exposed to chloroform for 13 wk. A

4 196 J Occup Health, Vol. 44, 2002 statistically significant decrease in the body weight gain was observed only in the 12 ppm-exposed male mice after the 7 wk exposure, as compared to the control. On the other hand, no such significantly decreased body weight gain was observed in any exposed group of female mice throughout the 13 wk exposure. The body weight gain of the male and female rats exposed to 50 ppm and above significantly decreased in a dose-related manner throughout the 13 wk exposure as compared to those of the respective controls. Absolute and relative weights of the kidneys and liver of female mice exposed to 200 ppm significantly increased as compared to those of control mice. On the other hand, there were no differences in absolute and relative weights of the kidneys and liver between the chloroform-exposed male mice and the controls. Relative weights of the liver and kidneys of male rats exposed to 50 ppm and above significantly increased as compared to those of the control, although absolute weights of those organs were not changed. The exposed female rats exhibited significant increases in the relative weight of the liver at 100 ppm and above, the absolute weight of the liver at 200 ppm and above, the relative weight of the kidneys at 50 ppm and above, and the absolute weight of the kidneys at 100 ppm and above. Histopathological changes Incidences of the main lesions in the animals exposed to chloroform vapor for 13 wk are summarized in Table 2. Mice: A statistically significant increase in the incidence of necrosis of proximal tubules was found in the males exposed to 12 ppm and above, whereas the tubular degeneration was found at 12 ppm but its incidence significantly increased at 25 ppm and above. Cytoplasmic basophilia (Fig. 3) of proximal tubules was observed in all the male mice which survived after the 13 wk exposure to chloroform, and its incidence was statistically significant at an exposure level of 12 ppm. On the other hand, cytoplasmic basophilia was not found in the male mice which died acutely after the first or second-day exposure to chloroform. Cytoplasmic basophilia was found only in a female mouse exposed to 100 ppm. The exposed females exhibited different histopathological changes in the liver and their incidences from the exposed males (Table 2). Necrosis and cell atypia of the liver (Fig. 4) were found in all the female mice exposed to 200 ppm and 100 ppm and above, respectively. Liver swelling did not occur in any exposed female, whereas this lesion was observed in all the males exposed to 200 ppm. There was also a gender difference in nasal lesions in the exposed mice (Table 2). A significantly increased incidence of degeneration of the olfactory epithelium was observed in the males exposed to 25 ppm and above, but that lesion did not occur in any exposed females. Statistically significant increases in the incidence of thickening of bone in the nasal septum (Fig. 5) and the eosinophilic changes of olfactory and respiratory epithelia were noted in the female mice exposed to 12 ppm and above. Although 7 cases of thickening of bone were observed in the 12 ppm-exposed males, the other two nasal lesions occurred rarely in the exposed male mice. Rats: A significantly increased incidence of vacuolic change (Fig. 6) in proximal tubules was noted in the females exposed to 200 ppm and above and in the males exposed to 400 ppm. It was confirmed histopathologically that there was no case of α2µ-globulin nephropathy in any control or exposed group of male rats. Liver collapse, e.g., the loss of hepatocytes (Fig. 7) as well as the deposit of ceroid was observed in the exposed rats, and those two lesions were rather localized in the central area of liver. The incidences of collapse and ceroid deposit significantly increased in the females exposed to 100 ppm and above and to 200 ppm and above, respectively, whereas those two lesions in male rats appeared at higher exposure levels than in females. Significantly increased incidences of the mineralization and the atrophy of the olfactory epithelium (Fig. 8) were seen in male and female rats exposed to 25 ppm and above. The incidence of necrosis of the olfactory epithelium significantly increased in males exposed to 200 ppm and above, whereas that lesion occurred only in one female rat exposed to 400 ppm. Urinary and biochemical parameters The urinary and blood biochemical parameters of both rats and mice of both sexes after inhalation exposure to chloroform for 13 wk are shown in Table 3. No significant difference between the 12 ppm-exposed male mice and the respective control was found in any blood biochemical parameters. Urinary protein was found in the male mice exposed to 12 ppm. Significant increases in serum levels of GOT, GPT and ALP were noted in the female mice exposed to 200 ppm, and a significant increase in BUN was also found in the female mice exposed to 50 ppm and above. No other marked changes in the biochemical parameters were observed for the female mice exposed to lower than 200 ppm. Serum levels of ALP, LAP and γ-gtp significantly increased in the female rats exposed to 200 and 400 ppm and in the male rats exposed to 400 ppm, as compared to those observed in the respective controls. Positive urinary glucose was observed only in male and female rats exposed to 400 ppm, whereas the serum level of glucose significantly decreased in the male rats exposed to 50 ppm and above and in the female rats exposed to 200 and 400 ppm. Occult blood occurred in the male rats exposed to 50 ppm and above and in the female rats exposed to 200 and 400 ppm. Urinary protein was found in the male rats exposed to 400 ppm.

5 Tatsuya KASAI, et al.: Acute and Subchronic Inhalation Toxicity of Chloroform 197 Table 2. Incidences of principal lesions in mice and rats of both sexes in the 13-wk exposure study (A) Mice Male Female Group Control 12 ppm 25 ppm 50 ppm 100 ppm 200 ppm Control 12 ppm 25 ppm 50 ppm 100 ppm 200 ppm Number of animals used Nasal cavity Degeneration of olfactory 0 2 5** 7** 6** 9** epithelium (2/2) (5/9) (7/10) (6/8) (9/10) Thickening of bone 0 7** ** 10** 9** 9** 9** Eosinophilic change of olfactory epithelium ** 9** 8** 9** 10** Eosinophilic change of respiratory epithelium ** 8** 7** 7** 8** Liver (central) Swelling ** (10/10) Cell atypia ** 10** Necrosis ** Vacuolic change Kidneys (proximal tubules) Tubular Necrosis 0 7** 10** 10** 9** 10** (2/2) (9/9) (10/10) (8/8) (10/10) Degeneration 0 2 9** 10** 8** 10** (2/2) (9/9) (10/10) (8/8) (10/10) Cytoplasmic basophilia 0 8** The parenthesis indicates the number of dead animals bearing a lesion/total number of animals which died during the 13-wk exposure period. (B) Rats Male Female Group Control 25 ppm 50 ppm 100 ppm 200 ppm 400 ppm Control 25 ppm 50 ppm 100 ppm 200 ppm 400 ppm Number of animals used Nasal cavity Mineralization 0 10** 10** 10** 10** 10** 0 10** 10** 10** 10** 10** Atrophy of olfactory epithelium 0 7** 10** 10** 9** 10** 0 10** 10** 10** 10** 10** Necrosis of olfactory epithelium ** 10** Liver (central) Deposit of ceroid ** ** 10** Collapse ** 10** ** 9** 9** Vacuolic change Kidneys (proximal tubules) Vacuolic change * ** 5** Significant difference; *: P 0.05, **: P 0.01 by Chi-square test. The animals which died during the exposure period are included in statistical analysis.

6 198 J Occup Health, Vol. 44, 2002 Fig. 3. Cytoplasmic basophilia in the kidney of a surviving male mouse exposed to 12 ppm chloroform for 13 wk. Fig. 4. Necrosis and cell atypia in the central area of the liver of a female mouse exposed to 200 ppm chloroform for 13 wk. Fig. 5. Thickening of bone in the septum of the nasal cavity of a female mouse exposed to 200 ppm chloroform for 13 wk. Fig. 6. Vacuolic change of the epithelium of proximal tubules in the kidney of a female rat exposed to 400 ppm chloroform for 13 wk. Fig. 7. Collapse, e.g., the loss of hepatocytes, and ceroid deposit in the central area of the liver of a male rat exposed to 400 ppm chloroform for 13 wk. Fig. 8. Necrosis and atrophy of the olfactory epithelium and mineralization in the ethmoturbinate of the nasal cavity of a male rat exposed to 200 ppm chloroform for 13 wk.

7 Tatsuya KASAI, et al.: Acute and Subchronic Inhalation Toxicity of Chloroform 199 Table 3. Biochemical blood analysis and urinalysis of surviving mice and rats of both sexes necropsied at termination of the repeated inhalation exposure to chloroform vapor for 13 wk (A) Mice Male Female Group Control 12 ppm 25 ppm 50 ppm 100 ppm 200 ppm Control 12 ppm 25 ppm 50 ppm 100 ppm 200 ppm Number of Animals used BIOCHEMISTRY Glucose (mg/dl) * 186* BUN (mg/dl) ** 34** 29* GOT (IU/l) ** GPT (IU/l) ** ALP (IU/l) * URINALYSIS Protein 2/10 8/8** 2/10 4/10 3/10 3/10 3/10 2/10 The data for male mice exposed to 25 and 100 ppm were not analyzed, because the number of animals surviving after the 13-wk exposure was too small. (B) Rats Male Group Control 25 ppm 50 ppm 100 ppm 200 ppm 400 ppm Control 25 ppm 50 ppm 100 ppm 200 ppm 400 ppm Female Number of Animals used BIOCHEMISTRY Glucose (mg/dl) * 159** 141** 117** ** 109** GOT (IU/l) GPT (IU/l) ALP (IU/l) * ** 344** LAP (IU/l) ** * 78** γ-gtp (IU/l) ** ** 11** URINALYSIS Glucose 0/10 0/10 0/10 0/10 3/10 8/10** 0/10 0/10 0/10 0/10 1/10 10/10** Occult blood 1/10 2/10 7/10** 7/10** 10/10** 9/10** 0/10 0/10 0/10 0/10 6/10** 7/10** Protein 1/10 3/10 3/10 4/10 2/10 7/10* 1/10 0/10 0/10 0/10 1/10 1/10 Significant difference; *: P 0.05, **: P 0.01, Biochemistry: by Dunnett s test, Urinalysis: by Chi-square test. BUN: blood urea nitrogen, GOT: glutamate oxaloacetate transaminase, GPT: glutamate pyruvate transaminase, ALP: alkaline phosphatase, γ-gtp: γ-glutamyl transpeptidase, LAP:leucine aminopeptidase. Discussion Chloroform toxicity in rodents It has been recognized that chloroform is metabolized primarily through the oxidative pathway to phosgene by the cytochrome P450, and that phosgene but not chloroform itself is responsible for manifestation of toxicity of inhaled or ingested chloroform 16). It was also reported that the CYP2E1 isozyme is enriched in the kidneys, liver and nasal organ 17 23). It was found in the present study that the kidneys, liver and nasal cavity are the principal organs damaged by acute and subchronic inhalation exposure to chloroform. Lesions in these three organs may be caused by either enhanced deposition of or site-specific tissue susceptibility to chloroform and/or its metabolite. Since tissue levels of inhaled chloroform were reported to be distributed widely throughout the body 9), it can be inferred that the acute and subchronic toxicities of inhaled chloroform are brought about by phosgene, depending on the localized metabolic capacity of the P450 enriched tissues such as the kidneys, liver, and nasal organ. In the present study, it was found that mice are more susceptible to acute and subchronic toxicities of inhaled chloroform than rats, as evidenced by a much lower lethal concentration in male mice than in female mice (Table 1) as well as lower LOAEL (12 ppm) for proximal tubular necrosis in male mice than in female mice (no tubular

8 200 J Occup Health, Vol. 44, 2002 necrosis found). The gender difference in susceptibility to chloroform toxicity between male and female mice is consistent with the result reported by Smith et al. 21), and can be explained in terms of greater metabolic capacity of renal CYP2E1 isozyme activities in males than in females 21, 22). No gender difference in susceptibility between male and female rats found in the present study can be accounted for by a modest difference in the CYP2E1 activity in male and female rat kidneys 18). Kidney, liver and nasal lesions The kidney lesions in male mice were characterized by necrosis, degeneration and cytoplasmic basophilia of proximal tubules occurring at the lowest exposure level of 12 ppm. No such kidney lesions were found in the exposed female mice, but the significantly increased BUN indicative of functional failure of the kidneys was observed in the female mice exposed to 50 ppm and above. The cytoplasmic basophilia which was observed in all 8 surviving male mice exposed to 12 ppm, indicative of the regenerative and proliferative response to necrosis, 24, 25) is consistent with the result reported by Larson et al. who observed increased cell proliferation as indicated by bromodeoxyuridine incorporated into the kidneys of male B6C3F 1 mice exposed to 10 ppm or below for 13 wk. The rat kidney lesions were characteristic of vacuolic change (fatty change) which might result from the necrosis, occurring at high exposure levels of 200 and 400 ppm. The present findings in the occult blood of the male and female rats, the positive urinary protein in the male rats and male mice and the increased BUN in the female mice may reflect functional failure of the kidneys. The positive urinary glucose occurring in the 400 ppmexposed rats of both sexes may correspond to the marked decrease in the blood glucose in the same 400 ppmexposed groups and be causally related to malfunctioning glucose reabsorption in proximal tubules. The present results on renal vacuolic change observed in the rats of both sexes exposed to the high exposure levels are consistent with those reported by Templin et al. 26) who reported that vacuolation of proximal tubules was observed only at 300 ppm. They also showed increased cell proliferation as measured by bromodeoxyuridine incorporated into the kidneys of rats of both sexes exposed to 90 ppm and above for 13 wk 26). Chloroform-induced liver lesions were characterized by collapse, ceroid deposit and vacuolic change in male and female rats, and swelling in male mice and cell atypia, necrosis and vacuolic change in female mice. These lesions may result from the necrosis of liver cells and reflect insufficient occurrence of the regenerative and proliferative response to the damaged liver cells. The high serum levels of the biomarkers indicative of necrosis of liver cells can be seen in GOT, GPT and ALP in female mice and ALP, LAP and γ-gtp in rats, all of which occurred at high exposure levels of 200 ppm in female mice, 200 ppm and above in female rats and 400 ppm in male rats. The histopathology of rat liver found in the present study essentially agrees with that reported by Templin et al. 26) who showed increased cell proliferation as indicated by bromodeoxyuridine incorporated into the liver of the rats exposed to 300 ppm for 13 wk. Although no clear cytoplasmic basophilia in mouse liver indicative of regenerative and proliferative response to liver necrosis 24, 25) was observed in the present study, Larson et al. reported that an increased cell proliferation index of liver was observed at 30 ppm for male and at 90 ppm for female mice. It was striking that in the present study the olfactory region of the nasal cavity of rats and mice of both sexes was very susceptible to chloroform exposure, because the nasal lesions occurred at the lowest exposure level of 12 ppm in mice and 25 ppm in rats. Since cytochrome P-450 is reported to be enriched in the olfactory region of the nasal cavity 17), the chloroform-induced lesions in the nasal cavity may be explained plausibly in terms of phosgene, a reactive metabolite of chloroform, rather than a direct action of the inhaled chloroform on the nasal tissues. The severity and spatial patterns of the nasal lesions in the chloroform-exposed rats and mice found in the present study are in essential agreement with those of bromodeoxyuridine immunolabeling following exposure of rats and mice to 300 ppm chloroform reported so far 27), but Mery et al. 27) suggested that CYP2E1 was not preferentially distributed in the regions in which the chloroform-induced nasal lesions occurred. Further study will be needed to explore other causative factors responsible for the nasal lesions, in addition to phosgene. There was a gender difference in the pattern of the nasal histopathology between male and female mice, because the degeneration of olfactory epithelium was observed in males, whereas the eosinophilic changes of olfactory and respiratory epithelia were observed in females. No such a gender difference was found between male and female rats. Species difference in toxicity Intentional or accidental exposure of humans to chloroform was reported to result in increased serum biomarkers of GOT, GPT and LDH indicative of liver cell necrosis followed by increased liver regeneration biomarkers of γ-gtp, alphafetoprotein and retinol-binding protein 28), symptoms of jaundice and hepatic coma, and liver degeneration and necrosis at autopsy 29). Occupational exposure to chloroform at about 1,950 ppm was reported to induce jaundice among 5 of 13 workers 30) and to result in 18 cases of jaundice among factory workers who were exposed to chloroform of 80 to 160 ppm for less than 4 months 31). Kluwe 32) reported that chloroform is readily metabolized in humans, presumably by the liver.

9 Tatsuya KASAI, et al.: Acute and Subchronic Inhalation Toxicity of Chloroform 201 Knowledge about a species difference in the susceptibility to chloroform toxicity between humans and rodents is of prime importance to extrapolate the rodents toxicity data to humans. The results of a physiologically based pharmacokinetic (PBPK) model for chloroform 33) suggested that the metabolic activation of chloroform to a toxic intermediate, phosgene, occurs most rapidly in mice, less rapidly in rats, and most slowly in humans. Amet et al. 23) reported that human kidney microsomes do not contain a significant amount of CYP2E1 and that the microsomal monooxygenase activities were much higher in the human liver than in human kidneys. Taking the above-mentioned findings 23, 33) into consideration, human acute chloroform poisoning may be characterized by the liver damage rather than kidney damage. NOAEL and LOAEL for OEL NOAELs and LOAELs for various endpoints of the exposed mice and rats can be determined from doseresponse relationships for the endpoints of general health status such as body and organ weights, histopathological changes and blood biochemical and urinary parameters. It was found in the present 13-wk inhalation exposure of rats to chloroform vapor that a value of 25 ppm is the LOAEL for the nasal endpoint and the NOAEL for the suppressed growth rate, increased blood glucose and positive occult blood. In the present mouse study, a value of 12 ppm was the LOAEL for the renal and nasal endpoints of histopathology and for the blood biochemical endpoint of the increased urinary protein and the NOAEL for the increased BUN. The NOAELs and LOAELs determined in the present study are comparable to those reported by Larson et al. 25) and Templin et al. 26) who found a concentration of 10 ppm to be the experimental NOAEL for induced proliferation in proximal tubules of male and female F344 rats and in the liver of female mice. Interestingly, the LOAELs of 25 ppm and 12 ppm for the nasal endpoint of the exposed rats and mice found in the present study, respectively, are comparable to those reported by Mery et al. 27). Because the biological significance of the nasal histopathology of the chloroformexposed rodents remains unclear, further study will be needed to correlate the histopathological lesions in the nasal organ with possible functional impairments of olfactory sensation, as demonstrated by a positive correlation between functional impairment of olfactory sensation and nasal histopathology of the severe degeneration of the olfactory region in the 3-methylindole-administered rat 34). The existing OEL values for chloroform 4, 6, 7) among ACGIH-TLV, JSOH-OEL and German MAK were derived primarily from the bioassay data of rodents exposed to chloroform vapor by inhalation. The value of 10 ppm set by both ACGIH-TLV and JSOH-OEL was derived from two independent studies which reported that repeated 7-h exposure of male rats to chloroform at ppm increased the relative liver and kidney weights 35, 36), whereas repeated 4-h exposure to the same concentration did not produce any liver lesion 36). The 10 ppm value is approximately equivalent to the 4-h exposure of rats to 25 ppm 36). On the other hand, the German MAK value of 0.5 ppm was based on a NOAEL of 5 ppm for an endpoint of increased cell proliferation in the liver and kidneys after inhalation exposure of rats and mice to chloroform for 13 wk 8). The cytolethality and subsequent cell proliferation in the kidneys and liver of the chloroform-exposed rodents are considered to be a crucial step in the development of chloroform-induced tumorigenesis as a non-genotoxic and cytotoxic mode of action 25, 26, 37, 38). In our companion paper 12), it was reported that two-year inhalation exposure of male mice to chloroform produces the sustained cytoplasmic basophilia in significant association with the renal cell adenoma and carcinoma. Therefore, the LOAELs and the NOAELs determined in the present study would provide additional information about basic toxicity data for risk assessment of workers exposed to chloroform by inhalation. Acknowledgments: The present study was contracted and supported by the Ministry of Labour of Japan (the present Ministry of Health, Labour and Welfare). References 1) Chemical Products Handbook The Chemical Daily Co., Tokyo, 2001: (in Japanese). 2) National Occupational Exposure Survey ( ). Cincinnati: National Institute for Occupational Safety and Health, ) Deinzer M, Schaumburg F, Klein E. Environmental Health Sciences Center Task Forces review on halogenated organics in drinking water. Environ Health Perspect 1978; 24: ) Threshold limit values (TLVs) for chemical substances TLVs and BEIs. Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati: ACGIH, 2002: 27. 5) Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th Edition. Cincinnati: ACGIH, 1991: ) Recommendation of Occupational Exposure Limits ( ) by the Japan Society for Occupational Health (JSOH). J Occup Health 2001; 43: ) Documentation of the occupational exposure limit for carbon tetrachloride and chloroform. Jpn J Ind Health 1991; 33: (in Japanese). 8) Chloroform. In: Greim H ed. Occupational Toxicants. Critical Data Evaluation for MAK Values and Classification of Carcinogens. Wiley-VCH Verlag GmbH, Weinheim: Germany, 2000: Vol ) Environmental Health Criteria 163 Chloroform. International Programme on Chemical Safety. Geneva: World Health Organization, 1994.

10 202 J Occup Health, Vol. 44, ) Andelman JB. Human exposures to volatile halogenated organic chemicals in indoor and outdoor air. Environ Health Perspect 1985; 62: ) Organization for Economic Co-operation and Development (OECD). Guidelines for Testing of Chemicals 412 for Repeated Dose Inhalation Toxicity: 28-d or 14-d Study and 413 for Subchronic Inhalation Toxicity: 90-day Study. Paris OECD, ) Yamamoto S, Kasai T, Matsumoto M, et al. Carcinogenicity and chronic toxicity in rats and mice exposed to chloroform by inhalation. J Occup Health 2002; 44: (submitted for publication). 13) Kano H, Goto K, Suzuki M, et al. An exposure system for combined administration of an organic solvent to rodents by inhalation and water-drinking and its operational performance. J Occup Health 2002; 44: ) Yamazaki M, Noguchi Y, Tanda S, Sintani S. Statistical methods appropriate for general toxicological studies in rats. Algorithms for multiple comparisons of treatment groups with control. J Takeda Res Lab 1981; 40: (in Japanese). 15) Hamada C, Yoshino K, Abe I, Matsumoto K, Nomura M, Yoshimura I. Detection of an outlier and evaluation of its influence in chronic toxicity studies. Drug Information J. 1998; 32: ) Toxicological Review of Chloroform (October 2001). In Support of Summary Information on the Integrated Risk Information System (IRIS). Washington DC: U.S. Environmental Protection Agency, ) Bond, JA. Metabolism of xenobiotics by the respiratory tract. In: DE. Gardner et al eds. Toxicology of the Lung, 2 nd ed. New York: Raven Press Ltd, 1993: ) Dahl AR, Hadley WH. Nasal cavity enzymes involved in xenobiotic metabolism: Effects on the toxicity of inhalants. Crit Rev Toxicol 1991; 21: ) Wilke AV, Clay AS, Borghoff SJ. Cytochrome P450 2E1 (P450 2E1) levels in male and female rat kidney: Implications for xenobiotic metabolism. Toxicologist 1994; 14: ) Constan AA, Sprankle CS, Peters JM, et al. Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. Toxicol Appl Pharm 1999; 160: ) Smith JH, Maita K, Sleight SD, Hook JB. Effect of sex hormone status on chloroform nephrotoxicity and renal mixed function oxidases in mice. Toxicol 1984; 30: ) Pohl LR, George JW, Satoh H. Strain and sex differences in chloroform-induced nephrotoxicity. Different rates of metabolism of chloroform to phosgene by the mouse kidney. Drug Metabolism and Disposition 1984; 12: ) Amet Y, Berthou F, Fournier G, et al. Cytochrome P450 4A and 2E1 expression in human kidney microsomes. Biochem Pharmacol 1997; 53: ) Larson JL, Wong DC, Morgan KT, Mery S, Butterworth BE. The toxicity of 1-week exposures to chloroform in female B6C3F1 mice and male F344 rats. Fundm Appl Toxicol 1994; 22: ) Larson JL, Templin MV, Wolf DC, et al. A 90-day chloroform inhalation study in female and male B6C3F1 mice: Implications for cancer risk assessment. Fundm Appl Toxicol 1996; 30: ) Templin MV, Larson JL, Butterworth BE, et al. A 90- day chloroform inhalation study in F344 rats: Profile of toxicity and relevance to cancer studies. Fundm Appl Toxicol 1996; 32: ) Mery S, Larson JL, Butterworth BE, Wolf DC, Harden R, Morgan KT. Nasal toxicity of chloroform in male F344 rats and female B6C3F1 mice following a 1-week inhalation exposure. Toxicol Appl Pharmacol 1994; 125: ) Rao KN, Virji MA, Moraca MA, Diven WF, Martin TG, Schneider SM. Role of serum markers for liver function and regeneration of chloroform poisoning. J Anal Toxicol 1993; 17: ) Goodman LS, Gilman AG. The pharmacological basis of therapeutics. New York: McMilan Co, Cited from p114. In: Environmental Health Criteria 163. International Programme on Chemical Safety. Geneva: WHO, ) Phoon WH, Liang OK, Kee CP. An epidemiological study of an outbreak of jaundice in a factory. Ann Acad Med Singap 1975; 4: ) Phoon WH, Goh KT, Lee LT, Tan KT, Kwok SF. Toxic jaundice from occupational exposure to chloroform. Med J Malays 1983; 38: ) Kluwe WM. In: Hook JB. ed. The nephrotoxicity of low molecular weight halogenated alkane solvents, pesticides and chemical intermediates. Toxicology of the Kidney. New York: Raven Press, Ltd, 1981; ) Corley RA, Mendrala AM, Gargas ML, et al. Development of physiologically based pharmacokinetic based model for chloroform. Toxicol Appl Pharmacol 1990; 103: ) Peele DB, Allison SD, Bolon B, Prah JD, Jensen KF, Morgan KT. Fuctional deficits produced by 3- methylindole-induced olfactory mucosal damage revealed by a simple olfactory learning task. Toxicol Appl Pharmacol 1991; ) Schwetz BA, Leong KL, Gehring PJ. Embryo and fetotoxicity of inhaled chloroform in rats. Toxicol Appl Pharmacol 1974; 28: ) Torkelson TR, Oyen F, Rowe VK. The toxicity of chloroform as determined by single and repeated exposure of laboratory animals. Am Ind Hyg Assoc J 1976; 37: ) Templin MV, Constan AA, Wolf DC, Wong BA, Butterworth BE. Patterns of chloroform-induced regenerative cell proliferation in BDF 1 mice correlate with organ specificity and dose-response of tumor formation. Carcinogenesis 1998; 19: ) Butterworth BE, Bogdanffy MS. A comprehensive approach for integration of toxicity and cancer risk assessments. Regul Toxicol Pharmacol 1999; 29:

Summary of Inhalation Carcinogenicity Study. of Tetrachloroethylene. in BDF 1 Mice

Summary of Inhalation Carcinogenicity Study. of Tetrachloroethylene. in BDF 1 Mice Summary of Inhalation Carcinogenicity Study of Tetrachloroethylene in BDF 1 Mice March 1993 Japan Bioassay Laboratory Japan Industrial Safety and Health Association PREFACE The tests were contracted and

More information

Summary of Inhalation Carcinogenicity Study. of Isopropyl Acetate. in F344 Rats

Summary of Inhalation Carcinogenicity Study. of Isopropyl Acetate. in F344 Rats Summary of Inhalation Carcinogenicity Study of Isopropyl Acetate in F344 Rats March 2009 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted

More information

OPINION of the French Agency for Environmental and Occupational Health Safety

OPINION of the French Agency for Environmental and Occupational Health Safety The Director General Maisons-Alfort, France, 15 June 2009 OPINION of the French Agency for Environmental and Occupational Health Safety Relating to establishing carcinogenic HTVs by inhalation for carbon

More information

of 3-Aminophenol in B6D2F1 Mice

of 3-Aminophenol in B6D2F1 Mice Summary of Drinking Water Carcinogenicity Study of 3-Aminophenol in B6D2F1 Mice July 2012 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted

More information

Summary of Feed Carcinogenicity Study. of Diphenylamine. in F344 Rats

Summary of Feed Carcinogenicity Study. of Diphenylamine. in F344 Rats Summary of Feed Carcinogenicity Study of Diphenylamine in F344 Rats August 2011 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted and supported

More information

Dithianon DITHIANON (180)

Dithianon DITHIANON (180) Dithianon 201 5.11 DITHIANON (180) TOXICOLOGY Dithianon (C 14 H 4 N 2 O 2 S 2 ) is the International Organization for Standardization (ISO) approved name for 5,10-dihydro-5,10-dioxonaphtho[2,3-b]-1,4-dithiine-2,3-dicarbonitrile

More information

IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE

IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE DRAFT CONSENSUS GUIDELINE IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS Released for

More information

5.15 HEXYTHIAZOX (176)

5.15 HEXYTHIAZOX (176) Hexythiazox 225 5.15 HEXYTHIAZOX (176) TOXICOLOGY Hexythiazox is the ISO approved name for (trans-5-(4-chlorophenyl)-n-cyclohexyl-4-methyl-2-oxo- 3-thiazolidine-carboxamide (CAS No. 78587-05-0). Hexythiazox

More information

Dr/ Sherein Saeid AbdElgayed, ph.d

Dr/ Sherein Saeid AbdElgayed, ph.d هللامسب Dr/ Sherein Saeid AbdElgayed, ph.d Professor of Veterinary Pathology, Cairo University, Giza, Egypt. Chairman of the Editorial Board of Arab Journal of Science & Research Publishing (AJSRP) http://www.ajsrp.com

More information

Ethylene Oxide

Ethylene Oxide Ethylene Oxide 75-21-8 Hazard Summary The major use of ethylene oxide is as a chemical intermediate in the manufacture of ethylene glycol. Ethylene oxide is also used as a sterilizing agent for medical

More information

CHLOROPICRIN VAPOR EXPOSURE RESULTING FROM TREATED FIELD VAPOR

CHLOROPICRIN VAPOR EXPOSURE RESULTING FROM TREATED FIELD VAPOR EMERGENCY MEDICAL TREATMENT GUIDE CHLOROPICRIN VAPOR EXPOSURE RESULTING FROM TREATED FIELD VAPOR SYNONYMS: Chloropicrin, Trichloronitromethane, Nitrochloroform (label names such as Tri- Clor and Tri-Pic).

More information

To: Recipients of JACC 42. HV/mls/JACC 42 corrigendum Brussels, 15 December 2004

To: Recipients of JACC 42. HV/mls/JACC 42 corrigendum Brussels, 15 December 2004 EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS AISBL To: Recipients of JACC 42 HV/mls/JACC 42 corrigendum Brussels, 15 December 2004 Dear Sir or Madam, Corrigenda to JACC No. 42 - Tetrafluoroethylene

More information

Summary. Scope. Physical and chemical properties

Summary. Scope. Physical and chemical properties Summary Scope At request of the Minister of Social Affairs and Employment, The Health Council of the Netherlands sets health-based recommended occupational exposure limits (HBR-OEL) for toxic substances

More information

5.36 THIOPHANATE-METHYL (077)

5.36 THIOPHANATE-METHYL (077) 391 5.36 THIOPHANATE-METHYL (077) TOXICOLOGY is the International Organization for Standardization (ISO) approved common name for dimethyl 4,4 -(o-phenylene)bis(3-thioallophanate) (International Union

More information

WHO/SDE/WSH/04.08/64s. Trihalomethanes in drinking-water Summary statement

WHO/SDE/WSH/04.08/64s. Trihalomethanes in drinking-water Summary statement WHO/SDE/WSH/04.08/64s Trihalomethanes in drinking-water Summary statement World Health Organization September 2004 WHO information products on water, sanitation, hygiene and health can be freely downloaded

More information

Max Chou Toxicologist and Certified Marine Chemist Trainee

Max Chou Toxicologist and Certified Marine Chemist Trainee Max Chou Toxicologist and Certified Marine Chemist Trainee Three Objectives: 1) Regulations regarding local toxic substances 2) Origin of regulations and extrapolation to maritime industry 3) The difference

More information

Correlation of Lethal Doses of Industrial Chemicals between Oral or Intraperitoneal Administration and Inhalation Exposure#

Correlation of Lethal Doses of Industrial Chemicals between Oral or Intraperitoneal Administration and Inhalation Exposure# Industrial Health 1998, 36, 273-281 Correlation of Lethal Doses of Industrial Chemicals between Oral or Intraperitoneal Administration and Inhalation Exposure# Takeshi HONMA* and Megumi SUDA Division of

More information

UPDATE ON A SAFE OCCUPATIONAL EXPOSURE LEVEL FOR 1-BROMOPROPANE. Prepared for EnviroTech Europe, Ltd.

UPDATE ON A SAFE OCCUPATIONAL EXPOSURE LEVEL FOR 1-BROMOPROPANE. Prepared for EnviroTech Europe, Ltd. UPDATE ON A SAFE OCCUPATIONAL EXPOSURE LEVEL FOR 1-BROMOPROPANE Prepared for EnviroTech Europe, Ltd. Prepared by Dr. Mark Stelljes SLR International Corporation Executive Summary This paper re-evaluates

More information

A Weight of Evidence Approach to Cancer Assessment. Alan R Boobis Imperial College London

A Weight of Evidence Approach to Cancer Assessment. Alan R Boobis Imperial College London A Weight of Evidence Approach to Cancer Assessment Alan R Boobis Imperial College London a.boobis@imperial.ac.uk Disclosure Statement Member of Board of Trustees of ILSI, Board of Directors of ILSI Europe

More information

Nations, All rights reserved ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM

Nations, All rights reserved ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM ANNEX AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM Annex AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM A.1 Classification proposal The following classification proposal

More information

Robert G. Sussman, Ph.D., DABT Managing Principal, Eastern Operations. SafeBridge Consultants, Inc. Mountain View, CA New York, NY Liverpool, UK

Robert G. Sussman, Ph.D., DABT Managing Principal, Eastern Operations. SafeBridge Consultants, Inc. Mountain View, CA New York, NY Liverpool, UK Robert G. Sussman, Ph.D., DABT Managing Principal, Eastern Operations SafeBridge Consultants, Inc. Mountain View, CA New York, NY Liverpool, UK Paracelsus (1493 1541) All substances are poisons; there

More information

Tetrachloroethylene: Integrated Risk Information System (IRIS) Draft Toxicological Review Kate Z. Guyton, PhD DABT

Tetrachloroethylene: Integrated Risk Information System (IRIS) Draft Toxicological Review Kate Z. Guyton, PhD DABT Tetrachloroethylene: Integrated Risk Information System (IRIS) Draft Toxicological Review Kate Z. Guyton, PhD DABT National Academy of Sciences Tetrachloroethylene Peer Review Panel November 13, 2008 NCEA

More information

ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE

ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE ANNEX 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM - 427 - Annex 8 AN EXAMPLE OF CLASSIFICATION IN THE GLOBALLY HARMONIZED SYSTEM A8.1 Classification proposal The following classification

More information

SAFETY ASPECTS OF MIDAZOLAM

SAFETY ASPECTS OF MIDAZOLAM Br. J. clin. Pharmac. (1983), 16, 37S-41S Biological Pharmaceutical Research Department, F. Hoffmann-La Roche & Co Ltd, CH-4002 Basle, Switzerland 1 The LD50 in the rat and the mouse is about 1600 mg/kg

More information

(Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017)

(Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017) WORKPLACE ENVIRONMENTAL EXPOSURE LEVEL (Z)-1-Chloro-2,3,3,3-tetrafluoropropene (2017) I. IDENTIFICATION Chemical Name: (Z)-1-Chloro-2,3,3,3-tetrafluoropropene Synonyms: HCFO-1224yd(Z) CAS Number: 111512-60-8

More information

NAPHTHALENE. Hazard Summary

NAPHTHALENE. Hazard Summary NAPHTHALENE Hazard Summary CAUTION: This file has been revised and no longer reflects the original document,"epa Health Effects Notebook for Hazardous Air Pollutants-Draft", EPA-452/D-95-00, PB95-50579,

More information

The Inhalation DNEL- Challenge

The Inhalation DNEL- Challenge The Inhalation DNEL- Challenge Jürgen Pauluhn Rome, October 1, 2010 Wuppertal, Germany First Step of Risk Characterization: Reference Concentration for Workers DNEL = derived no effect level - the level

More information

Risk Assessment Approaches for Nanomaterials

Risk Assessment Approaches for Nanomaterials Risk Assessment Approaches for Nanomaterials Eileen D. Kuempel, PhD Nanotechnology Research Center Education and Information Division National Institute for Occupational Safety and Health The findings

More information

Interim Specific Ground Water Criterion o, m, p-cresol. Alan H. Stern, Dr.P.H., D.A.B.T. Office of Science NJDEP 2/25/10

Interim Specific Ground Water Criterion o, m, p-cresol. Alan H. Stern, Dr.P.H., D.A.B.T. Office of Science NJDEP 2/25/10 Interim Specific Ground Water Criterion o, m, p-cresol Alan H. Stern, Dr.P.H., D.A.B.T. Office of Science NJDEP 2/25/10 Introduction Scope of this Assessment The purpose of this assessment is to derive

More information

IS AMBIENT HYDROGEN SULFIDE A RISK TO HUMAN HEALTH? Sarah R. Armstrong, M.S., D.A.B.T. Michael R. Ames, Sc.D. and Laura C. Green, Ph.D., D.A.B.T.

IS AMBIENT HYDROGEN SULFIDE A RISK TO HUMAN HEALTH? Sarah R. Armstrong, M.S., D.A.B.T. Michael R. Ames, Sc.D. and Laura C. Green, Ph.D., D.A.B.T. IS AMBIENT HYDROGEN SULFIDE A RISK TO HUMAN HEALTH? Sarah R. Armstrong, M.S., D.A.B.T. Michael R. Ames, Sc.D. and Laura C. Green, Ph.D., D.A.B.T. Cambridge Environmental Inc. 58 Charles St. Cambridge,

More information

Exposure to 2,2-Dichloro-1,1,1-trifluoroethane (HCFC-123) and Acute Liver Dysfunction: A Causal Inference

Exposure to 2,2-Dichloro-1,1,1-trifluoroethane (HCFC-123) and Acute Liver Dysfunction: A Causal Inference J Occup Health 1998; 40: 334 338 Journal of Occupational Health Exposure to 2,2-Dichloro-1,1,1-trifluoroethane (HCFC-123) and Acute Liver Dysfunction: A Causal Inference Toru TAKEBAYASHI 1, Isamu KABE

More information

The Importance of ADME/PK to Inform Human Safety Assessments Based on Animal Studies: Example with Furan. Gregory L. Kedderis, PhD Chapel Hill, NC

The Importance of ADME/PK to Inform Human Safety Assessments Based on Animal Studies: Example with Furan. Gregory L. Kedderis, PhD Chapel Hill, NC The Importance of ADME/PK to Inform Human Safety Assessments Based on Animal Studies: Example with Furan Gregory L. Kedderis, PhD Chapel Hill, NC Conflict of Interest None This research was conducted at

More information

TLVs for Nanoparticles. Terry Gordon, PhD Chair, TLV Committee

TLVs for Nanoparticles. Terry Gordon, PhD Chair, TLV Committee TLVs for Nanoparticles Terry Gordon, PhD Chair, TLV Committee OELs for Nanoparticles? No EU OELs National initiatives Germany OEL for silica dioxide UK benchmark levels pragmatic guidance 0.066 x OEL insoluble

More information

Table of Contents. 1. Occurrence/use Health Significance... 4 Recommendation... 5 Key Bibliography... 6

Table of Contents. 1. Occurrence/use Health Significance... 4 Recommendation... 5 Key Bibliography... 6 Recommendation from the Scientific Expert Group on Occupational Exposure Limits for pentane, isopentane and neopentane SEG/SUM/79 Table of Contents 1. Occurrence/use... 4 2. Health Significance... 4 Recommendation...

More information

INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE Q3D(R1)

INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE Q3D(R1) INTERNATIONAL CONCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED GUIDELINE GUIDELINE FOR ELEMENTAL IMPURITIES (R1) Draft version Endorsed on 18 May 2018

More information

Practical approaches for endocrine toxicity in preclinical safety assessment

Practical approaches for endocrine toxicity in preclinical safety assessment Practical approaches for endocrine toxicity in preclinical safety assessment Akira Inomata, D.V.M., Ph.D., D.J.S.T.P. Tsukuba Drug Safety, Global Drug Safety, Biopharmaceutical Assessments Core Function

More information

Exposure Dose Health Effects

Exposure Dose Health Effects Exposure Dose Health Effects Understanding the links Elaine Symanski, PhD Mary Ann Smith, PhD The starting basis* How are pollutant levels detected and measured in the human body? If there is some level

More information

DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *)

DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *) DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS *) Guideline Title Dose Selection for Carcinogenicity Studies of Pharmaceuticals *) Legislative basis Directive 75/318/EEC as amended Date

More information

Hazard Communication Standard Contents

Hazard Communication Standard Contents Hazard Communication Standard Contents C.4.19 FLAMMABLE LIQUIDS (Classified in Accordance with Appendix B.6) Hazard category Signal word Hazard statement 1 Danger Extremely flammable liquid and vapor

More information

Carcinogenicity Test of 2-Ethoxy-2-methylpropane in Rats (Inhalation Study)

Carcinogenicity Test of 2-Ethoxy-2-methylpropane in Rats (Inhalation Study) (Study No. 0686) FINAL REPORT Carcinogenicity Test of 2-Ethoxy-2-methylpropane in Rats (Inhalation Study) Study No.: 0686 March 25, 2010 Japan Industrial

More information

Methodologies for development of human health criteria and values for the lake Erie drainage basin.

Methodologies for development of human health criteria and values for the lake Erie drainage basin. 3745-1-42 Methodologies for development of human health criteria and values for the lake Erie drainage basin. [Comment: For dates of non-regulatory government publications, publications of recognized organizations

More information

Page 1132

Page 1132 Page 1131 Page 1132 Page 1133 Page 1134 Page 1135 Huntingdon Life Sciences 03-6140 Page 6. Final Report TABLE OF CONTENTS Page 1136 COVER PAGE...1 GLP STATEMENT...2 SIGNATURE PAGE...3 QUALITY ASSURANCE

More information

5.17 PENTHIOPYRAD (253)

5.17 PENTHIOPYRAD (253) Penthiopyrad 189 5.17 PENTHIOPYRAD (253) TOXICOLOGY Penthiopyrad is the International Organization for Standardization (ISO) approved name for N-[2- (1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide

More information

Industrial Toxicology

Industrial Toxicology Industrial Toxicology Learning Objectives Know the assumptions of the doseresponse and time-course curves Be able to define and label key points of a curve Know the difference between potency and efficacy

More information

Dose and Response for Chemicals

Dose and Response for Chemicals Dose and Response for Chemicals 5 5 DOSE AND RESPONSE FOR CHEMICALS All substances are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy. Paracelsus, 16th

More information

Chloroform. CAS number Structural formula CHCl 3 Molecular weight

Chloroform. CAS number Structural formula CHCl 3 Molecular weight Chloroform MAK value (1999) 0.5 ml/m 3 2.5 mg/m 3 Peak limitation (1983) II,1 Absorption through the skin (1999) H Sensitization Carcinogenicity (1999) Category 4 Prenatal toxicity (1999) C Germ cell mutagenicity

More information

GENERAL PRINCIPLES OF TOXICOLOGY

GENERAL PRINCIPLES OF TOXICOLOGY GENERAL PRINCIPLES OF TOXICOLOGY Laboratory of toxicology Department of Pharmacology and Toxicology College of Pharmacy, University of Baghdad 2015 TOXICOLOGY - PRACTICAL SYLLABUS 2015 General Principles

More information

Distinguishing between Mode and Mechanism of Action

Distinguishing between Mode and Mechanism of Action Distinguishing between Mode and Mechanism of Action Michael Dourson Toxicology Excellence for Risk Assessment Center University of Cincinnati College of Medicine Conflict of Interest Statement The research

More information

ICH Topic S1B Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals. Step 5

ICH Topic S1B Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals. Step 5 European Medicines Agency March 1998 CPMP/ICH/299/95 ICH Topic S1B Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON CARCINOGENICITY: TESTING FOR CARCINOGENICITY

More information

Risk Assessment Report on Vinyl acetate. Human Health Part. CAS No.: EINECS No.:

Risk Assessment Report on Vinyl acetate. Human Health Part. CAS No.: EINECS No.: Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on Vinyl acetate Human Health Part CAS No.: 108-05-4 EINECS No.: 203-545-4 The SCHER adopted this opinion at its 26 th

More information

Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?

Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Regulatory Toxicology and Pharmacology 41 (2005) 128 133 Regulatory Toxicology and Pharmacology www.elsevier.com/locate/yrtph Are tumor incidence rates from chronic bioassays telling us what we need to

More information

Tasks of BAuA. Toxicity and Risk of DCM and alternative solvents in paint strippers. baua_vorlagen.ppt

Tasks of BAuA. Toxicity and Risk of DCM and alternative solvents in paint strippers. baua_vorlagen.ppt Toxicity and Risk of DCM and alternative solvents in paint strippers Tasks of BAuA Support the ministry of labour (BMA) Implementation and transfer of knowledge Research Dr. B. Orthen Toxicology of hazardous

More information

Risk Assessment Report on styrene. Human Health Part

Risk Assessment Report on styrene. Human Health Part Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on styrene Human Health Part CAS No.: 100-42-6 EINECS no.: 202-851-5 SCHER adopted this opinion at its 23 rd plenary

More information

Determination of Noncancer Chronic Reference Exposure Levels Batch 2A December 2000 CHRONIC TOXICITY SUMMARY GLUTARALDEHYDE

Determination of Noncancer Chronic Reference Exposure Levels Batch 2A December 2000 CHRONIC TOXICITY SUMMARY GLUTARALDEHYDE CHRONIC TOXICITY SUMMARY GLUTARALDEHYDE (1,5-pentanedial; 1,5-pentanedione; glutaric dialdehyde; Aldesen; Cidex; Sonacide) CAS Registry Number: 111-30-8 I. Chronic Toxicity Summary Inhalation reference

More information

CANCER HAZARD IDENTIFICATION STRATEGIES PROJECT COMMITTEE

CANCER HAZARD IDENTIFICATION STRATEGIES PROJECT COMMITTEE CANCER HAZARD IDENTIFICATION STRATEGIES PROJECT COMMITTEE Mission The mission of the HESI Cancer Hazard Identification Strategies (CHIS) Project Committee was to consider new strategies that can offer

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Obese Type 2 Diabetic Model. Rat Model with Early Onset of Diabetic Complications. SDT fatty rats. SDT fatty rats

Obese Type 2 Diabetic Model. Rat Model with Early Onset of Diabetic Complications. SDT fatty rats. SDT fatty rats Obese Type 2 Diabetic Model rats Rat Model with Early Onset of Diabetic Complications rats Background and Origin In 24, Dr. Masuyama and Dr. Shinohara (Research Laboratories of Torii Pharmaceutical Co.,

More information

MATERIAL SAFETY DATA SHEET NAPA Canadian Brake Parts Cleaner

MATERIAL SAFETY DATA SHEET NAPA Canadian Brake Parts Cleaner Product Name: Product Number: Product Use: Manufacturer/Supplier: MATERIAL SAFETY DATA SHEET Section 1: PRODUCT AND COMPANY IDENTIFICATION 4700C Cleaner. NAPA P. O. Box 421268, Indianapolis IN, 46241 Phone

More information

Study of the main chemical components of Ganoderma lucidum

Study of the main chemical components of Ganoderma lucidum Study of the main chemical components of Ganoderma lucidum Yasuo Komota et al Tokyo Medical and Dental University [Purpose] As part of the means for exerting quality control on Ganoderma lucidum 50% ethanol

More information

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH

SHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH IN RATS SUB CHRONIC ORAL TOXICITY WITH NHH 44 Bt-COTTON SEEDS Report for: UNIVERSITY OF AGRICULTURAL SCIENCES AGRICULTURAL RESEARCH STATION DHARWAD-580007 KARNATAKA Guidelines: DBT, Guidelines for Toxicity

More information

Part 2. Chemical and physical aspects

Part 2. Chemical and physical aspects Part 2. Chemical and physical aspects 12. Chemical and physical aspects: introduction 12.1 Background information used The assessment of the toxicity of drinking-water contaminants has been made on the

More information

CHARACTERIZING THE IMPACTS OF UNCERTAINTY AND SCIENTIFIC JUDGMENT IN EXPOSURE LIMIT DEVELOPMENT

CHARACTERIZING THE IMPACTS OF UNCERTAINTY AND SCIENTIFIC JUDGMENT IN EXPOSURE LIMIT DEVELOPMENT CHARACTERIZING THE IMPACTS OF UNCERTAINTY AND SCIENTIFIC JUDGMENT IN EXPOSURE LIMIT DEVELOPMENT Andrew Maier, Ph.D., CIH, DABT TERA Robert Sussman, Ph.D., DABT SafeBridge Consultants, Inc. Bruce Naumann,

More information

Hexavalent Chromium Oral Reference Dose

Hexavalent Chromium Oral Reference Dose Development Support Document Proposed, June Hexavalent Chromium Oral Reference Dose CAS Registry Number: 0-- Prepared by Joseph T. Haney, Jr., M.S. Toxicology Division Office of the Executive Director

More information

Nonclinical Safety Evaluation of Inhalation Drug Products

Nonclinical Safety Evaluation of Inhalation Drug Products Nonclinical Safety Evaluation of Inhalation Drug Products February 13, 2002 Life Science Research Organization Bethesda, Maryland Luqi Pei, Ph.D. Division of Pulmonary and Allergy Drug Products Center

More information

Study of the main chemical components of Ganoderma lucidum

Study of the main chemical components of Ganoderma lucidum Study of the main chemical components of Ganoderma lucidum Yasuo Komota et al Tokyo Medical and Dental University [Purpose] As part of the means for exerting quality control on Ganoderma lucidum 50% ethanol

More information

Committee for Risk Assessment RAC. Opinion. on the specific target organ toxicity of 2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV- 320)

Committee for Risk Assessment RAC. Opinion. on the specific target organ toxicity of 2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV- 320) Committee for Risk Assessment RAC Opinion on the specific target organ toxicity of 2-benzotriazol-2-yl-4,6-di-tert-butylphenol (UV- 320) EC number: 223-346-6 CAS number: 3846-71-7 and 2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol

More information

Opinion on. Classification of Musk ketone

Opinion on. Classification of Musk ketone EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON HEALTH AND ENVIRONMENTAL RISKS SCHER

More information

FDA Expectations and Evaluation of Inhalation Toxicology Studies

FDA Expectations and Evaluation of Inhalation Toxicology Studies FDA Expectations and Evaluation of Inhalation Toxicology Studies Presented by Timothy McGovern, Ph.D. SciLucent, LLC Herndon, Virginia Development of inhalation products has unique regulatory aspects My

More information

Histologic and histomorphometric changes of testis following oral exposure to methyl tertiary-butyl ether in adult rat

Histologic and histomorphometric changes of testis following oral exposure to methyl tertiary-butyl ether in adult rat 288 Histologic and histomorphometric changes of testis following oral exposure to methyl tertiary-butyl ether in adult rat Gholami, S. 1* ; Ansari-Lari, M. 2 and Khalili, L. 3 1 Department of Basic Sciences,

More information

ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. Step 5

ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals. Step 5 European Medicines Agency October 2008 EMEA/CHMP/ICH/383/1995 ICH Topic S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON DOSE SELECTION FOR CARCINOGENICITY

More information

3-MCPD and glycidol and their esters

3-MCPD and glycidol and their esters Toxicological Risk Assessment of 3-monochloropropane-1,2-diol (3-MCPD) Esters and Glycidol Esters: Is there a Need for Concern? Ivonne M.C.M. Rietjens Division of Toxicology Wageningen University ivonne.rietjens@wur.nl

More information

DISCUSSION GROUP 3. Mechanism of carcinogenicity. EFSA Scientific Colloquium on Acrylamide carcinogenicity, 22/23 May

DISCUSSION GROUP 3. Mechanism of carcinogenicity. EFSA Scientific Colloquium on Acrylamide carcinogenicity, 22/23 May DISCUSSION GROUP 3 Mechanism of carcinogenicity EFSA Scientific Colloquium on Acrylamide carcinogenicity, 22/23 May 2008 1 1. Review the recent evidence for the mutagenicity and genotoxicity of acrylamide

More information

Hexane (all isomers except n-hexane)

Hexane (all isomers except n-hexane) Hexane (all isomers except n-hexane) Classification/MAK value: MAK value dates from: 1991 Synonyms: isohexane 200 ml/m 3 (ppm) 700 mg/m 3 2,3-dimethylbutane dimethylpropylmethane diethylmethylmethane ethyl-trimethylmethane

More information

Risk Assessment Issues: Asbestos p. 100 Review of Epidemiological Evidence for Health Effects in Workers Exposed to MMMFs p. 103

Risk Assessment Issues: Asbestos p. 100 Review of Epidemiological Evidence for Health Effects in Workers Exposed to MMMFs p. 103 Preface Contributors Introduction and Background p. 1 Characterization of Chemical Contaminants p. 2 Human Exposures and Dosimetry p. 7 Chemical Exposures and Dose-to-Target Tissues p. 7 Concentration

More information

HL-60 ATP assay for predicting rat oral toxicity study

HL-60 ATP assay for predicting rat oral toxicity study AATEX 14, Special Issue, 699-703 Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences August 21-25, 2007, Tokyo, Japan HL-60 ATP assay for predicting rat oral toxicity study Yumiko

More information

TUMORS OF SPRAGUE-DAWLEY RATS INDUCED BY LONG-TERM FEEDING OF PHENACETIN*1

TUMORS OF SPRAGUE-DAWLEY RATS INDUCED BY LONG-TERM FEEDING OF PHENACETIN*1 TUMORS OF SPRAGUE-DAWLEY RATS INDUCED BY LONG-TERM FEEDING OF PHENACETIN*1 Hidehiko ISAKA, Hirooki YOSHII, Akinobu OTSUJI, Masao KOIKE, Yuichiro NAGAI, Masatoshi KOURA, Koichiro SUGIYASU, and Teruhiko

More information

formic acid ethyl ester

formic acid ethyl ester Formic acid ethyl ester MAK value (1961) 100 ml/m 3 (ppm) 3.10 mg/m 3 Peak limitation (2000) Category I, excursion factor 1 Absorption through the skin (1997) H Sensitization Carcinogenicity Prenatal toxicity

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Safety Data Sheet ULTRAPLAN RENOVATION

Safety Data Sheet ULTRAPLAN RENOVATION Safety Data Sheet dated 13/5/2010, version 1 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING Trade name: Product type and use: Cement based levelling mortar. Supplier: MAPEI

More information

The Director General Maisons-Alfort, 22 December 2017 OPINION. of the French Agency for Food, Environmental and Occupational Health & Safety

The Director General Maisons-Alfort, 22 December 2017 OPINION. of the French Agency for Food, Environmental and Occupational Health & Safety The Director General Maisons-Alfort, 22 December 2017 OPINION of the French Agency for Food, Environmental and Occupational Health & Safety on the development of a chronic TRV by the respiratory route

More information

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP)

APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP) 1 (10) Helsinki, 09 September 2016 RAC/38/2016/09 rev 1 Final APPLICATION FOR AUTHORISATION: ESTABLISHING REFERENCE DNELs FOR 1-BROMOPROPANE (1-BP) Background At the 22 nd meeting of the Committee for

More information

AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z

AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z AMENDED FINAL REPORT Author Deborah A Douds, M.S. Original Study Completion Date July 8, 1997 Amended Study Completion Date November 19, 1997 Performing

More information

Folpet (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief

Folpet (Pesticides) Summary. Risk assessment report. Food Safety Commission of Japan. Conclusion in Brief 2017 Food Safety Commission, Cabinet Office, Government of Japan doi: 10.14252/foodsafetyfscj.2017002s Food Safety 2017; Vol. 5, No. 2, 67 71 Risk assessment report Folpet (Pesticides) Summary Food Safety

More information

TLV Definition. airborne concentrations which it is believed that nearly all workers may be repeatedly exposed without adverse health effects.

TLV Definition. airborne concentrations which it is believed that nearly all workers may be repeatedly exposed without adverse health effects. TLV Definition airborne concentrations which it is believed that nearly all workers may be repeatedly exposed without adverse health effects. TLV Basis/Critical Effects Health impairments considered include

More information

5.3 AZINPHOS METHYL (002)

5.3 AZINPHOS METHYL (002) 5.3 AZINPHOS METHYL (002) TOXICOLOGY Azinphos-methyl is the ISO approved common name for S-3,4-dihydro-4-oxo-1,2,3-benzotriazin-3- ylmethyl O,O-dimethyl phosphorodithioate (IUPAC) or O,O-dimethyl S-[(4-oxo-1,2,3-benzotriazin-

More information

N-Methylneodecanamide (MNDA)

N-Methylneodecanamide (MNDA) United States Prevention, Pesticides EPA-730-F-99-008 Environmental Protection And Toxic Substances July 1999 Agency (7505C) New Pesticide Fact Sheet Description of the Chemical N-Methylneodecanamide (MNDA)

More information

ENZYME MARKERS OF TOXICITY

ENZYME MARKERS OF TOXICITY Why do we need enzyme markers? ENZYME MARKERS OF TOXICITY In vivo monitoring Serial sampling Early detection of metabolic changes Detection of organ-specific effects Establishment of NO EFFECT level Determination

More information

Toxicology. Toxicity. Human Health Concerns. Health Effects of Hazardous Materials

Toxicology. Toxicity. Human Health Concerns. Health Effects of Hazardous Materials Human Health Concerns Health Effects of Hazardous Materials Toxicology Study of the nature, effects, and detection of poisons in organisms Humans are obvious focal point Other species and ecosystem function

More information

REFERENCE DATA SHEET ON COMMON CHLORINATED SOLVENTS By Richard Gullickson, CIH

REFERENCE DATA SHEET ON COMMON CHLORINATED SOLVENTS By Richard Gullickson, CIH February 1993 REFERENCE DATA SHEET ON COMMON CHLORINATED SOLVENTS By Richard Gullickson, CIH POTENTIAL PROBLEM AREAS AND USES Dry cleaning operations Fluorocarbon manufacture Solvents for fats, oils, waxes,

More information

Acute Oral Toxicity Study in Rats with Argentyn 23 (EPA/OECD Guidelines) Study Title. Monica M. Vegarra, BS. Sponsor

Acute Oral Toxicity Study in Rats with Argentyn 23 (EPA/OECD Guidelines) Study Title. Monica M. Vegarra, BS. Sponsor Note: This study was done using our Professional strength 23 ppm product (Argentyn 23), therefore making Sovereign Silver at 10 ppm, 2.3 times safer. Conclusion on page 6 shows the product to be non-toxic

More information

Establishing the Relevance of Health Hazard Data for GHS Classification: Adverse vs. Non-Adverse

Establishing the Relevance of Health Hazard Data for GHS Classification: Adverse vs. Non-Adverse Establishing the Relevance of Health Hazard Data for GHS Classification: Adverse vs. Non-Adverse Robert Roy, Ph.D. SCHC Fall Meeting Diplomate, American Board of Toxicology September 30, 2014 1 Disclaimer

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

TOXICOLOGICAL PROFILE FOR 1,2-DICHLOROETHENE

TOXICOLOGICAL PROFILE FOR 1,2-DICHLOROETHENE TOXICOLOGICAL PROFILE FOR 1,2-DICHLOROETHENE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry August 1996 1,2-DICHLOROETHENE ii DISCLAIMER

More information

Material Safety Data Sheet 47Industrial Park, Lilydale, Victoria 3140 Phone: Fax:

Material Safety Data Sheet 47Industrial Park, Lilydale, Victoria 3140 Phone: Fax: This substance is classified as Hazardous according to the criteria of Worksafe Australia. Not classified as Dangerous Goods according to the criteria of ADG code. 1. MATERIAL AND SUPPLY COMPANY IDENTIFICATION

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OSTREM CHEMICAL CO. LTD. Phone: 780-440-1911 or 780-446-0177 2310-80 AVENUE In Case of Emergency Only: EDMONTON AB T6P 1N2 phone CANUTEC at (613) 996-6666 Product

More information

CAS-No. EC-No. Index-No. Concentration Chloroform-d May be harmful if inhaled. May cause respiratory tract irritation.

CAS-No. EC-No. Index-No. Concentration Chloroform-d May be harmful if inhaled. May cause respiratory tract irritation. SIGMA-ALDRICH Material Safety Data Sheet Version 3.3 01/11/2008 Print Date 08/31/2011 1. PRODUCT AND COMPANY IDENTIFICATION Product name : Product Number : C8513 Brand : Sigma Company : Sigma-Aldrich 3050

More information

Parasite Suspensions in Formalin

Parasite Suspensions in Formalin Section 1 Identification Parasite Suspensions in Formalin Product Name: Parasite Suspensions Manufacturer: Microbiologics, Inc. Telephone Number: 320-253-1640 Address: 200 Cooper Avenue North St. Cloud,

More information

Greenline Plywood Products Ltd.

Greenline Plywood Products Ltd. Greenline Plywood Products Ltd. MATERIAL SAFTY DATA SHEET SECTION #1 COMPANY IDENTIFICATION Name: Fineline Reconstituted Wood Veneer Date: August 15, 2007 Wood: Fineline Company Information Greenline Plywood

More information

SILICA, CRYSTALLINE (RESPIRABLE DUST)

SILICA, CRYSTALLINE (RESPIRABLE DUST) SILICA, CRYSTALLINE (RESPIRABLE DUST) CAS number: Cristobalite 14464-46-1 Quartz 14808-60-7 Tridymite 15468-32-3 Tripoli 1317-95-9 Synonyms: Chemical formula: α quartz, crystallized silicon dioxide, silica,

More information

Potassium Dichromate Impact on Male Reproductive Integrity Biomarker in Rat. Two Generation Study

Potassium Dichromate Impact on Male Reproductive Integrity Biomarker in Rat. Two Generation Study Potassium Dichromate Impact on Male Reproductive Integrity Biomarker in Rat. Two Generation Study Jelena Rankov, Alexandra Trif, Diana Brezovan, Florin Muselin Faculty of Veterinary Medicine 300645, Timisoara,

More information